Seaweed extracts and polysaccharides are effective candidates for developing drugs and functional nutrition products to treat inflammatory bowel disease.
Inflammatory Bowel Disease Seaweed
The methodology summarized in this research paper encompasses examining natural compounds, specifically derived from seaweed, which could potentially serve as therapeutic agents for IBD. Concentrating on the unique structural features of algal polysaccharides, the researchers observed their interaction with several factors associated with IBD, such as proinflammatory cytokines, chemokines, adhesion molecules, intestinal epithelial cells, and reactive oxygen and nitrogen.
In discussing the results, it was seen that the seaweed extracts and polysaccharides show promise in influencing key therapeutic targets related to IBD, suggesting their potential utility in the development of treatment options for patients. These include drugs, biological food additives, and functional nutrition products. This conclusion was drawn by noting the influence of these extracts and polysaccharides on immune and epithelial cells as well as intestinal microorganisms.
View Article
